US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

265.79

+4.791.84%

Pre-market: 261.68-4.1100-1.55%06:02 EDT

Volume:295.12K

Turnover:79.09M

Market Cap:604.54M

PE:- -

High:276.21

Open:265.34

Low:259.25

Close:261.00

52wk High:341.93

52wk Low:93.20

Shares:2.27M

Float Shares:2.27M

Volume Ratio:0.66

T/O Rate:12.98%

Dividend:0.90

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Sector Update: Healthcare

MT Newswires Live

Exchange-Traded Funds Lower as US Equities Decline After Midday

MT Newswires Live

Cryoport management to meet with BTIG

Diagnos Seeks U.S. FDA Clarity on AI-Powered CARA Eye Screening System

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

CapsoVision Wins FDA Clearance for AI Endoscopy Tool

King International Wins Shareholder Backing for Share Consolidation and Major Rights Issue

CervoMed neflamapimod update removes key overhang, says Jones

Oncolytics Advances Pelareorep Trial, Gains FDA Alignment

Powerful NeOnc Brain Cancer Pipeline Advances

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Agilon Health (AGL)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Lakefront Biotherapeutics (LKFT) and 10x Genomics (TXG)

Health Care Select Sector SPDR: Pivot points

Bayer announces FDA accepts Lynkuet sNDA for Priority Review

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212

Palvella receives third year of grant funding from FDA for QTORIN

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and IQVIA Holdings (IQV)

U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":265.79,"timestamp":1790798400000,"preClose":261,"halted":0,"volume":295118,"hourTrading":{"tag":"盘前","latestPrice":261.68,"preClose":265.79,"latestTime":"06:02 EDT","volume":879,"amount":231808.47359999997,"timestamp":1790848955530,"change":-4.11,"changeRate":-0.015463,"amplitude":0.02976},"delay":0,"changeRate":0.01835249042145602,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Pre-Mkt","change":4.79,"latestTime":"10-01 06:09:24 EDT","open":265.34,"high":276.21,"low":259.25,"amount":79086093.48868,"amplitude":0.064981,"askPrice":263.6,"askSize":200,"bidPrice":260,"bidSize":201,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.79,"sharesOutstanding":3074486,"nav":260.661,"aum":592869955.42,"dividendRate":0.0034,"bidAskSpread":0.003436,"preHourTrading":{"tag":"盘前","latestPrice":261.68,"preClose":265.79,"latestTime":"06:02 EDT","volume":879,"amount":231808.47359999997,"timestamp":1790848955530,"change":-4.11,"changeRate":-0.015463,"amplitude":0.02976},"postHourTrading":{"tag":"盘后","latestPrice":266.5,"preClose":265.79,"latestTime":"19:59 EDT","volume":2105,"amount":559351.6497,"timestamp":1790812786487,"change":0.71,"changeRate":0.002671,"amplitude":0.007525},"volumeRatio":0.6630229218183342,"impliedVol":0.9528,"impliedVolPercentile":0.676},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6630229218183342,"shares":2274486,"dividePrice":0.9037,"high":276.21,"amplitude":0.064981,"preClose":261,"low":259.25,"week52Low":93.2,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":265.79,"committee":0.002494,"eps":0,"divideRate":0.0034,"volume":295118,"delay":0,"ttmEps":0,"open":265.34,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":253.11,"twentyDayClose":300.7,"sixtyDayClose":322.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671505252","title":"Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505252","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505252?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625600,"startTime":"0","endTime":"0","summary":"DEGEVMA is now FDA-approved across all indications of the reference product, Xgeva (denosumab), to help prevent bone complications in adults with advanced cancer that has spread to the bone, for the t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3370248/0/en/teva-continues-biosimilar-momentum-with-u-s-fda-approval-of-degevma-denosumab-adet-a-biosimilar-to-xgeva-denosumab.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BBP","MVF","BK4585","BK4156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257344","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257344?lang=en_us&edition=fundamental","pubTime":"2026-09-29 03:32","pubTimestamp":1790623963,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each adding 0.3%.The iShares Biotechnology ETF  rose 0.8%.In corporate news, Eli Lilly  plans to pursue larger pharmaceutical deals as it looks to expand into new therapeutic areas, Bloomberg reported, citing an interview with CEO David Ricks on the sidelines of a diabetes conference in Milan. Ricks cited infectious disease, women's health, and psychiatric conditions as possible areas of opportunity in a broadening search for pharmaceutical deals, the report said. Lilly shares were up 0.4%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LLII","LU1989771016.USD","LU1868837300.USD","SG9999018857.SGD","LU0823434583.USD","LU2468319806.SGD","BK4585","LU1145028129.USD","IE0001KFT4U8.USD","BK4588","IE00B7KXQ091.USD","ELIS","LU2108987350.USD","LU0354030511.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1868836914.USD","SG9999014914.USD","GDOC","LU0061475181.USD","LU2471134879.HKD","LU0889565916.HKD","LU2361044865.SGD","LU2746668974.SGD","IBB","LU0203202063.USD","LU1023059063.AUD","SG9999013999.USD","LU0320765059.SGD","LU0466842654.USD","LU1720051017.SGD","OZEM","LU2089284900.SGD","LU2491050154.USD","SGXZ51526630.SGD","SG9999018865.SGD","LU0079474960.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","IE00BJJMRX11.SGD","LU0225283273.USD","LU2111349929.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1814569148.SGD","LU2456880835.USD","LU2106854487.HKD","PPH","LU1366192091.USD","LU2023250504.SGD","BK4599","VHT","LU0471298777.SGD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","LU2168564495.EUR","LU2462591350.SGD","IE0009355771.USD","LU0094547139.USD","IE00BKDWB100.SGD","SG9999017495.SGD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU1868837136.USD","MHIP","LU0683600562.USD","LABU","LU1974910355.USD","LU0096364046.USD","CURE","SGXZ57979304.SGD","LU0786609619.USD","IE00BFSS8Q28.SGD","BK4581","LU0787776722.HKD","LU1868836591.USD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU2265009873.SGD","LU2471134952.CNY","XLV","LU0133085943.USD","LU2360106947.USD","LU0882574055.USD","HRTS","TMED","IE0004445015.USD","LU0689472784.USD","IE0004445239.USD","LU0256863811.USD","LU0672654240.SGD","SG9999014906.USD","SGXZ81514606.USD","LU0820561818.USD","LU2324357040.USD","LU2063271972.USD","LU0823416689.USD","LU0353189680.USD","IE00B1XK9C88.USD","RXL","PJP","SG9999001176.USD","LU0345770308.USD","SG9999014880.SGD","LU0266013472.USD","LU0456855351.SGD","LU2168564065.EUR","LU2750360641.GBP","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU2471134523.USD","LU0203201768.USD","LU1069344957.HKD","LU2756315664.SGD","LU1323610961.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0943347566.SGD","LU0471298694.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU0353189763.USD","LU1868836757.USD","LU1232071149.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","LU2491050071.SGD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","LU0320765992.SGD","LU2237443549.SGD","MEDX","LU1720051108.HKD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","XBI","LU2236285917.USD","LU0385154629.USD","LU0158827781.USD","IHE","LU1267930730.SGD","SG9999001176.SGD","LU0417517546.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","ILDR","SGXZ99366536.SGD","LU0345770993.USD","LU0820562030.AUD","SG9999015986.USD","LU1623119135.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","CANC","LU1551013425.SGD","LU0640476718.USD","LU2237443978.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0109391861.USD","LU2112291526.USD","LU2361045086.USD","LU2750360997.AUD","LU2462157665.USD","LU2211815571.USD","LU0114720955.EUR","IE00BWXC8680.SGD","SG9999015978.USD","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU2213496289.HKD","LU2237443382.USD","IYH","LU0122379950.USD","LU1127390331.HKD","LU2028103732.USD","IE00B2B36J28.USD","LU2089283258.USD","FTXH","LU1093756168.USD","BK4533","LU2271345857.HKD","LU0316494557.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1548497426.USD","SG9999015945.SGD","LU0210536198.USD","LU1291159041.SGD","BK4516","LLY","IE00BK4W5L77.USD","LU0432979614.USD","BK4007","LU1691799644.USD","LU2023251221.USD","LU2602419157.SGD","IE00BN29S564.USD","MEDI","IE00BJLML261.HKD","LU0158827948.USD","LU1035775433.USD","LU0097036916.USD","LU1804176565.USD","LLYX","THNR","LU2237443895.HKD","IE00BKPKM429.USD","LU2756315318.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2264538146.SGD","LU0289739699.SGD","LU1988902786.USD","LU1629891620.HKD","LU1983299246.USD","LU1093756325.SGD","SG9999015952.SGD","LU1979441026.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU1280957306.USD","LU0323591593.USD","LU1917777945.USD","ELIL","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671543832","title":"Exchange-Traded Funds Lower as US Equities Decline After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2671543832","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671543832?lang=en_us&edition=fundamental","pubTime":"2026-09-29 01:26","pubTimestamp":1790616373,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV fell. Actively traded Invesco QQQ Trust (QQQ) shed 1%.US equity indexes fell in midday trading on Monday as oil prices and Treasur","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BITX","GPIQ","BK4504","SPYU","BRRR","ETHT","BK4593","CBTO","BITO","MMAX","BK4561","NJAN","ETH","VHT","SPDN","XBTY","XLV","RSSL","CBXO","IWMI","SOXL","URTY","XLP","SSO","CBXY","SPXS","CBXA","XLI","USG","YBTC","PSQ","XLPD","BITB","ETH.USD.CC","QQQ","UPRO","XLF","BITU","IGLD","BK4547","QBF","SPXL","IWN","QMAR","YSPY","NAPR","SCO","SGOL","IAU","GLL","IWF","BITY","IAUI","VIS","CBXJ","SPYQ","CBOO","IAUM","USSX","UGL","IYW","TZA","BETE","QDEC","QID","FAS","SPUU","UWM","SOXX","EETH","BTC","BTRN","VTWO","HODL","BTCI","VB","BTF","MAXI","HIBL","BK4585","EZBC","QQQM","RYLD","CBTJ","USO","DEFI","IBB","BFJL","TNA","SLV","ZSL","IGM","OUNZ","BK4534","DFII","IBIT","SPXU","NDX","ETQ","DGZ","BETH","BAGY","FAZ","SRTY","DULL","CBTY","SPY","CBOA","MNRS","BTCO","AVUV","SIVR",".SPX","XLK","TQQY","AGQ","GLDY","RTH","DGP","ESK","BTCW","XLPU","BFAP","BAR","SQQQ","UCO","XAGUSD.FOREX","UNG","XAUUSD.FOREX","BCCC","BK4535","QQQX","AAAU","SPYM","KGLD","TWM","IYH","IVV","GLD","BK4570","BK4588","IYJ","SPYH","BTCL","SOXS","BTC.USD.CC","BTCC","TETH","MNQmain","TECL","CBTA","DZZ","NJUL","RETL","ARKB","SMAX","CBOY","GLDM","LABU","BPI","XSD","ETHD","XLE","XLY","SBIT","NOCT","BTCZ","SETH","IYE","XBI","FBTC","CBOJ","RWM","ETCO","QLD","VDC","SH","IWM","SDS","GBTC","TQQQ","BGLD","SHNY","BK4550","FGDL","BK4581","DMAX","BITI","XRT","YGLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671254672","title":"Cryoport management to meet with BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254672","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671254672?lang=en_us&edition=fundamental","pubTime":"2026-09-29 01:25","pubTimestamp":1790616317,"startTime":"0","endTime":"0","summary":"Healthcare IT & Digital Health Analyst Larsen holds a Field Trip to New York on October 7 and New Jersey on October 8 hosted by BTIG. Published fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cryoport-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cryoport-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4585","LABU","VGT","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671515512","title":"Diagnos Seeks U.S. FDA Clarity on AI-Powered CARA Eye Screening System","url":"https://stock-news.laohu8.com/highlight/detail?id=2671515512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671515512?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:36","pubTimestamp":1790613382,"startTime":"0","endTime":"0","summary":"An announcement from Diagnos ( ($TSE:ADK) ) is now available. Diagnos has submitted a Section 513(g) Request for Information to the U.S. Food and D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/diagnos-seeks-u-s-fda-clarity-on-ai-powered-cara-eye-screening-system?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/diagnos-seeks-u-s-fda-clarity-on-ai-powered-cara-eye-screening-system?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","AGIX","CARA","LABU","ARTY","VTHR","BK4585","BK4588","BK4007","QTOC","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2106854487.HKD","IBB","LU0823416689.USD","LU0823434740.USD","BBH","LABU","XLV","LU1917777945.USD","KOD","LU2362541273.HKD","XBI","LU0114720955.EUR","HCSG","LU0109394709.USD","LU2089984988.USD","LU2362540622.SGD","LU0053666078.USD","LU2468319806.SGD","LU2362541513.USD","TBXU","BK4588","LU0058720904.USD","LU0289739699.SGD","LU0128526141.USD","IBBQ","LU2023250504.SGD","LU0889565916.HKD","LU0320765992.SGD","REGN","LU0029874061.USD","BK4581","BK4505","BK4137","BK4585","LU2237438978.USD","LU0823434583.USD","BK4139","LU1974910355.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256083","title":"CapsoVision Wins FDA Clearance for AI Endoscopy Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256083?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:27","pubTimestamp":1790609272,"startTime":"0","endTime":"0","summary":"CapsoVision, Inc. ( ($CV) ) has shared an update. CapsoVision, Inc., a NASDAQ-listed medical technology company specializing in AI-enabled capsule ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/capsovision-wins-fda-clearance-for-ai-endoscopy-tool?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/capsovision-wins-fda-clearance-for-ai-endoscopy-tool?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","AGIX","NVIW.SI","ONEQ","QQQY","VTHR","ARTY","TQQY","NDX",".IXIC","CV","HTEC","QQQJ","TECS","QQQA","03086","DTEC","GPIQ","QTOC","TQQQ","MDEV","QID","XHE","LABU","FTEC","PSQ","SQQQ","FWD","QQQE","QQQM","QDTE","MNQmain","JEPQ","AIPO","QYLG","QLD","QQQ","BK4588","CHAT","IYW","BK4585","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256150","title":"King International Wins Shareholder Backing for Share Consolidation and Major Rights Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256150?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:08","pubTimestamp":1790608084,"startTime":"0","endTime":"0","summary":"Life Healthcare Group ( ($HK:0928) ) has issued an update. King International Investment Limited has secured shareholder approval for a share conso...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/king-international-wins-shareholder-backing-for-share-consolidation-and-major-rights-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/king-international-wins-shareholder-backing-for-share-consolidation-and-major-rights-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","MNA","BK4585","LABU","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670253220","title":"CervoMed neflamapimod update removes key overhang, says Jones","url":"https://stock-news.laohu8.com/highlight/detail?id=2670253220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670253220?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:05","pubTimestamp":1790604345,"startTime":"0","endTime":"0","summary":"Jones analyst Boris Peaker says CervoMed (CRVO) announced this morning that the FDA removed neflamapimod’s prior drug exposure limit, allowing the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cervomed-neflamapimod-update-removes-key-overhang-says-jones-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cervomed-neflamapimod-update-removes-key-overhang-says-jones-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588","BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670258046","title":"Oncolytics Advances Pelareorep Trial, Gains FDA Alignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2670258046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670258046?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:58","pubTimestamp":1790603935,"startTime":"0","endTime":"0","summary":"An announcement from Oncolytics Biotech ( ($ONCY) ) is now available. On September 28, 2026, Oncolytics Biotech reported operational progress in it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncolytics-advances-pelareorep-trial-gains-fda-alignment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncolytics-advances-pelareorep-trial-gains-fda-alignment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","XBI","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670309255","title":"Powerful NeOnc Brain Cancer Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2670309255","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670309255?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:51","pubTimestamp":1790603460,"startTime":"0","endTime":"0","summary":"November 17 FDA Meeting Set to Discuss Dosing and Trial Size for Second Drug in PipelineDENVER, Sept.  28, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369955/0/en/powerful-neonc-brain-cancer-pipeline-advances.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4007","BK4588","BK4585","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670523034","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2670523034","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670523034?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:00","pubTimestamp":1790600407,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down a slight 0.2%.Kodiak Sciences  stock was up more than 99% after the company said its two experimental eye drugs, Zenkuda and tabirafusp-ted, met primary endpoints in a Phase 3 study in patients with wet age-related macular degeneration.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","XBI","BK4137","BK4585","BK4581","BK4588","IBB","HCSG","LU0029874061.USD","LU0128526141.USD","KOD","LABU","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670342230","title":"Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Agilon Health (AGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670342230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670342230?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:51","pubTimestamp":1790599908,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hinge Health, Inc. Class A (HNGE) and Agilon Healt...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hinge-health-inc-class-a-hnge-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hinge-health-inc-class-a-hnge-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGL","BK4585","BK4196","HNGE","LABU","BK4581","BK4588","LU0128526141.USD","LU0029874061.USD","BK4539","HCSG","XBI","BK4137","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237166","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Lakefront Biotherapeutics (LKFT) and 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237166?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:30","pubTimestamp":1790598641,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ascendis Pharma (ASND), Lakefront Biotherapeutics ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ascendis-pharma-asnd-lakefront-biotherapeutics-lkft-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ascendis-pharma-asnd-lakefront-biotherapeutics-lkft-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXG","LU0889565916.HKD","BK4121","LU0320765992.SGD","LU0109394709.USD","LU0128526141.USD","LU0029874061.USD","LU1861558580.USD","LABU","HCSG","LU0963586101.USD","BK4581","BK4585","XBI","ASND","BK4588","BK4137","ARKG","MEDI","XLV","BK4548","BK4139","FMED","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237949","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237949?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:27","pubTimestamp":1790598430,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $171.99, Pivot Low: $169.68. These were calculated usi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-151?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-151?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4585","XBI","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670623274","title":"Bayer announces FDA accepts Lynkuet sNDA for Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2670623274","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670623274?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:10","pubTimestamp":1790597423,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that the U.S. Food and Drug Administration has accepted the company’s supplemental New Drug Application and granted Priorit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-announces-fda-accepts-lynkuet-snda-for-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-announces-fda-accepts-lynkuet-snda-for-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232424","title":"NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232424","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232424?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:00","pubTimestamp":1790596800,"startTime":"0","endTime":"0","summary":"November 17 meeting will address Phase 2 study design and potential regulatory pathwaysCALABASAS, Calif., Sept.  28, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369839/0/en/neonc-technologies-announces-fda-end-of-phase-1-meeting-for-neo212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4135","BK4585","CNS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234701","title":"Palvella receives third year of grant funding from FDA for QTORIN","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234701?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:50","pubTimestamp":1790596216,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics (PVLA) announced that the Company has received a third year of grant funding from the FDA Office of Orphan Products Developme...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palvella-receives-third-year-of-grant-funding-from-fda-for-qtorin-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palvella-receives-third-year-of-grant-funding-from-fda-for-qtorin-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PVLA","BK4585","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234690","title":"Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and IQVIA Holdings (IQV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234690?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:32","pubTimestamp":1790595120,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xencor (XNCR) and IQVIA Holdings (IQV) with bullish ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xencor-xncr-and-iqvia-holdings-iqv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xencor-xncr-and-iqvia-holdings-iqv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4530","IQV","LU0130517989.USD","LU0198837287.USD","LU0130103400.USD","HCSG","LU0477156953.USD","LU0648001328.SGD","LU0648000940.SGD","XLV","BK4585","BK4581","BK4588","LU0029874061.USD","LU0130518102.USD","LU0882574055.USD","EKG","XBI","LU0528227936.USD","BK4137","BK4121","LABU","LU0128526141.USD","LU1791710400.SGD","BK4139","LU1201861165.SGD","LU1261432733.SGD","LU1989764748.USD","LU1201861249.SGD","HEAL","LU0980610538.SGD","XNCR","LU0477156797.USD","LU1791710582.SGD","LU0130102774.USD","LU1989764664.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234567","title":"U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234567","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234567?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595000,"startTime":"0","endTime":"0","summary":"NDA submission completed following positive Phase 3 SELVA results; potential U.S. commercial launch in the first half of 2027, if approved QTORIN rapamycin has the potential to become the first FDA-ap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369784/0/en/u-s-food-and-drug-administration-awards-additional-funding-for-qtorin-rapamycin-for-the-treatment-of-microcystic-lymphatic-malformations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LABU","NVIB","BMED","HYLG","GDOC","BK4588","BK4585","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":6,"totalSize":395,"code":"91000000","status":"200"}]}}